Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA tracking reg letter

This article was originally published in The Gray Sheet

Executive Summary

FDA's device center will send a letter to manufacturers of penile implants and partial and total temporomandibular joints in the next several weeks informing the firms of their responsibilities under device tracking regulations due to go into effect in August. Penile and TMJ implants will be added to the list of devices that must be tracked in an upcoming revision to the final rule, according to FDAers ("The Gray Sheet" Dec. 14, 1992, p. 25).

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000772

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel